knowledge -WSS

knowledge

author：explore 2025-08-23 08:54:26 - browse：9269

-- health policy coverage from STAT — Protestors outside America's Health Insurance Plans headquarters. Courtesy People's Action

WASHINGTON — Hundreds of activists rallied today outside of the headquarters of the country’s largest health insurance lobbying group to protest against restrictions to coverage in private Medicare plans.

The protesters were crammed into an already busy part of the city. A 10-minute walk from the Capitol building and a block off the National Mall, the headquarters for America’s Health Insurance Plans is located in a part of Washington that is crowded with tourists during the summer. The protesters, organized by a group called People’s Action, left messages on the sidewalk in chalk that included “You make us sick,” and “for-profit health ‘care’ killed my mom.”

People’s Action has worked with high-profile progressive lawmakers, including Sen. Elizabeth Warren (D-Mass.), to push for lower drug prices and Medicare for All.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Health AI adoption puts security, privacy startups on investors' radar

WSS

Free speech concerns arise in wake of journal editor Eisen's firing

Senate panel clears PBM, hopsital reforms

U.K. researchers warn about biases in medical devices, algorithms

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Excited delirium, Elijah McClain, and emergency physicians

UCSF medical school apologizes for unethical prisoner experiments

Wikipedia

knowledge

knowledge

Moonlake's readout produced a cash windfall. Risks remain

Nurses recount patients attacks

Sports medicine is finally prioritizing gender equality

Readout Newsletter: Bluebird, CVS, Contineum

The cancer drug shortage isn’t new — and neither are the solutions

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Alkermes shareholders re

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Medicare details structure of new drug price negotiation program

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

hotspot

Physicians and social media: If you see something, say something?

Intermittent fasting comes with a heart risk? Not so fast

FDA approves Recor Medical high blood pressure device

CVS Caremark has created a new ploy: the drug ‘rebate credit’

App could help diagnose ear infections more accurately — and at home

Asbestos, a deadly carcinogen, banned by EPA

knowledge

entertainment

hotspot

entertainment